Russell Investments Group
PSTX

Russell Investments Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Russell Investments Group’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,566
Closed -$58.8K – 3817
2024
Q3 		$58.8K Sell
20,566
-18,175
-47% -$56.3K ﹤0.01% 2759
2024
Q2 		$113K Buy
38,741
+4,238
+12% +$11.6K ﹤0.01% 2602
2024
Q1 		$110K Buy
+34,503
New +$115K ﹤0.01% 2563
2022
Q3 		– Sell
-8,421
Closed -$21K – 2991
2022
Q2 		$21K Sell
8,421
-986
-10% -$2.74K ﹤0.01% 2797
2022
Q1 		$42K Sell
9,407
-18,771
-67% -$84.6K ﹤0.01% 2638
2021
Q4 		$191K Sell
28,178
-9,484
-25% -$64.6K ﹤0.01% 2725
2021
Q3 		$274K Sell
37,662
-1,465
-4% -$12.6K ﹤0.01% 2678
2021
Q2 		$391K Buy
39,127
+23,939
+158% +$214K ﹤0.01% 2695
2021
Q1 		$144K Buy
+15,188
New +$149K ﹤0.01% 2907

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Russell Investments Group's PSTX Position: Q4 2024 in Review

Russell Investments Group sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2024, closing a stake of 20,566 shares — an estimated $58.8K sold.

Russell Investments Group first reported a position in PSTX in Q1 2021 and held it in 9 quarters. The position peaked at $391K in Q2 2021. 115 funds tracked by Wall St. Rank hold PSTX as of Q4 2024.

  • Russell Investments Group reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 20,566 Poseida Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $58.8K.
  • Russell Investments Group first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Russell Investments Group's Poseida Therapeutics, Inc. Common Stock position peaked at $391K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.